5-Chloro-3-methyl-1H-indole-2-carboxylic acid, 95.0%, 1g

2-butylcyclopropanecarboxylic acid, 95.0%, 1g

1-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazole, 1g

Indium(III)-sulfat, min. 99,99 %, p.a., 10 g, kunststoffverpackung.

5-Bromopyrimidine>98.0%(GC)25g

2-Fluoro-5-methoxy-3-(trifluoromethyl)phenylacetic acid, 5g

3-(4-Chlorophenyl)-2-oxopropyl acetate, 98%, 1g

METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE, 95%, 5g

3-(3-Fluorophenyl)-1,1,1-trifluoro-2-propanone, 97.0%, 2g

2-amino-N-(2,3-dimethylphenyl)acetamide hydrochloride, 95.0%, 5g

4-(2-Piperidin-1-yl-ethoxy)-phenylamine, 25g

N,O-Bis(trimethylsilyl)trifluoroacetamide Kit BSTFA 1 mL * 8 / Reaction vial, capacity 2 mL * 81kit

2'-O,4'-C-Methylenecytidine, 250mg